Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma
Clinical trial NCT04979442 · TERMINATED
Trial details
- NCT number
- NCT04979442
- Sponsor
- Rain Oncology Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2023-10-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.